Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia

Abstract

The main goal of this clinical research study is to learn if Velcade ® (bortezomib) given with rituximab can help to control WM. This drug combination will allow researchers to collect your stem cells in case it is possible to transplant the stem cells as treatment if your WM gets worse. Researchers will also look at the safety and tolerability of this drug combination followed by treatment with other drug combinations. Phase: PHASE2 Status: ACTIVE_NOT_RECRUITING Conditions: Waldenstrom's Macroglobulinemia Interventions: Bortezomib; Rituximab; Valacyclovir

Keywords

Sources